NR3C1 and cancer: The progression of breast cancer is initiated by increasing stress hormone and glucocorticoid levels, which subsequently activates secondary site glucocorticoid receptors, enhances cancer colonization, and decreases survival rates.202 This suggests the use of caution when treating cancer patients with glucocorticoid therapy.